EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025 21.02.2025 / 08:30 CET/CEST The issuer is solely responsible for the content of this...
Abivax is a France-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer, viral and inflammatory diseases.